Investigation of the impact of urine handling procedures on interpretation of urinalysis findings and product safety in subjects treated with ezogabine

BACKGROUND: Ezogabine (also known by the international nonproprietary name of retigabine) is an antiepileptic drug codeveloped and comarketed by Valeant Pharmaceuticals North America and GlaxoSmithKline, which reduces neuronal excitability by enhancing the activity of potassium channels and has the...

Descripción completa

Detalles Bibliográficos
Autores principales: Brickel, Neil, DeRossett, Sarah, Buraglio, Mauro, Evans, Christopher, Jones, Siôn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650885/
https://www.ncbi.nlm.nih.gov/pubmed/23671389
http://dx.doi.org/10.2147/TCRM.S42536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650885/
https://www.ncbi.nlm.nih.gov/pubmed/23671389
http://dx.doi.org/10.2147/TCRM.S42536

Ejemplares similares